We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-7.49%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$2.45B
AUM Growth
-$331M
Cap. Flow
-$447M
Cap. Flow %
-18.22%
Top 10 Hldgs %
43.96%
Holding
111
New
16
Increased
20
Reduced
24
Closed
16

Top Buys

Rank Stock Value
1
MIRM icon
Mirum Pharmaceuticals
MIRM
+$42.3M
2
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$42.2M
3
AERI
Aerie Pharmaceuticals
AERI
+$35.2M
4
SWTX
SpringWorks Therapeutics
SWTX
+$24.8M
5
CNC icon
Centene
CNC
+$20.3M

Top Sells

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$27.7M
2
IMMU
Immunomedics Inc
IMMU
+$26M
3
STAA icon
STAAR Surgical
STAA
+$25.8M
4
NVRO
NEVRO CORP.
NVRO
+$25M
5
NVTA
Invitae Corporation
NVTA
+$23.4M

Sector Composition

Rank Sector Weight
1 Healthcare 71.17%
2 Financials 0.3%
3 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHAS
101
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
– –
-851,005
Closed -$11.2M
PFNX
102
DELISTED
Pfenex Inc.
PFNX
– –
-394,255
Closed -$2.66M
1 2 3 4
5

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q3 2019 Portfolio in Review

As of Q3 2019, Deerfield Management held 111 positions worth $2.45B, down 12% from $2.78B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Deerfield Management withdrew a net $447M in Q3 2019, closing 16 positions and reducing 24 holdings. Its most notable exit was Natera, an estimated $27.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, up from 68% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Deerfield Management opened a new position in Mirum Pharmaceuticals worth $34.7M.

  • Deerfield Management's largest Q3 2019 buy was Mirum Pharmaceuticals: 3,448,912 shares worth $34.7M.
  • Deerfield Management added most to Rhythm Pharmaceuticals in Q3 2019, an estimated $42.2M increase.
  • Deerfield Management's biggest Q3 2019 reduction was Immunomedics Inc, cutting an estimated $26M.
  • Deerfield Management fully exited Natera in Q3 2019, selling an estimated $27.7M.
  • Deerfield Management's ten largest holdings make up 44% of its $2.45B portfolio in Q3 2019.
  • Deerfield Management opened 16 new positions and closed 16 in Q3 2019.
  • Deerfield Management's portfolio value fell 12% quarter-over-quarter to $2.45B.

Based on Deerfield Management's 13F filing for Q3 2019, filed 14 Nov 2019.